Stereotaxis, Inc. completed its acquisition of Robocath, a French company, on July 7, 2026. The transaction involved the issuance of 6,269,628 shares of common stock and includes potential earnout consideration of up to $25 million in cash or shares. Stereotaxis, Inc. is a medical device company specializing in in situ magnetic navigation technology.
